Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Economic Times
The Economic Times

Mark Zuckerberg backed-Cellular Intelligence acquires Novo Nordisk's Parkinson's cell therapy

Meta CEO Mark Zuckerberg backed-Cellular Intelligence has acquired ​Danish drugmaker Novo Nordisk's ​cell therapy candidate for Parkinson's disease, the biotech ​firm said on Monday.

Last October, Novo Nordisk had shut down its cell therapy unit as part of a broader restructuring, discontinuing development ‌of ⁠the therapy.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.